cepharanthine has been researched along with Hepatitis B in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, JH; Ma, F; Sun, CY; Wang, N; Wang, QD; Wang, YF; Yang, XA; Yin, DT; Zhang, Y; Zheng, LY; Zhou, YB | 1 |
1 other study(ies) available for cepharanthine and Hepatitis B
| Article | Year |
|---|---|
In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Topics: Adult; Antiviral Agents; Benzylisoquinolines; Cell Survival; China; DNA, Viral; Down-Regulation; Drug Resistance, Viral; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatocytes; HSC70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Lamivudine; Male; Recombinant Proteins; RNA, Messenger; Virus Replication | 2012 |